Abstract
ATP-binding cassette (ABC) transporter genes are ubiquitously present in most organisms from bacteria to man. This gene family is the largest one known as of yet. Still growing, the number of human ABC transporters counts currently 47 members which belong to seven subfamilies. ABC transporters share a similar molecular architecture (1) Full-structured transporters harbor two symmetric halves each consisting of one nucleotide binding domain (NBD) and one transmembrane domain (TMD). (2) Half-transporters with one NBD and one TMD homo- or heterodimerize to functional transporter complexes. ABC transporters are traffic ATPases which hydrolyze ATP and which transport a wide array of molecules or conduct the transport of molecules by stimulating other translocation mechanisms. Many ABC transporters are involved in human inherited or sporadic diseases such as cystic fibrosis, adrenoleukodystrophy, Stargardts disease, drug-resistant tumors, Dubin-Johnson syndrome, Bylers disease, progressive familiar intrahepatic cholestasis, X-linked sideroblastic anemia and ataxia, persistent hyperinsulimenic hypoglycemia of infancy, and others. The present review summarizes the current findings in basic research and the efforts for bridging the gap to clinical applications in therapy and diagnostics.
Keywords: ATP-binding cassette (ABC) transporter genes, nucleotide binding domain (NBD), transmembrane, domain (TMD), Adrenoleukodystrophy, Drug resistance tumors, Progressive familiar intrahepatic cholestasis, Bacillus subtilis, x-linked sideroblastic anemia, Bylers disease, Johnson syndrome
Current Molecular Medicine
Title: The Human ATP-Binding Cassette Transporter Genes From the Bench to the Bedside
Volume: 1 Issue: 1
Author(s): Thomas Efferth
Affiliation:
Keywords: ATP-binding cassette (ABC) transporter genes, nucleotide binding domain (NBD), transmembrane, domain (TMD), Adrenoleukodystrophy, Drug resistance tumors, Progressive familiar intrahepatic cholestasis, Bacillus subtilis, x-linked sideroblastic anemia, Bylers disease, Johnson syndrome
Abstract: ATP-binding cassette (ABC) transporter genes are ubiquitously present in most organisms from bacteria to man. This gene family is the largest one known as of yet. Still growing, the number of human ABC transporters counts currently 47 members which belong to seven subfamilies. ABC transporters share a similar molecular architecture (1) Full-structured transporters harbor two symmetric halves each consisting of one nucleotide binding domain (NBD) and one transmembrane domain (TMD). (2) Half-transporters with one NBD and one TMD homo- or heterodimerize to functional transporter complexes. ABC transporters are traffic ATPases which hydrolyze ATP and which transport a wide array of molecules or conduct the transport of molecules by stimulating other translocation mechanisms. Many ABC transporters are involved in human inherited or sporadic diseases such as cystic fibrosis, adrenoleukodystrophy, Stargardts disease, drug-resistant tumors, Dubin-Johnson syndrome, Bylers disease, progressive familiar intrahepatic cholestasis, X-linked sideroblastic anemia and ataxia, persistent hyperinsulimenic hypoglycemia of infancy, and others. The present review summarizes the current findings in basic research and the efforts for bridging the gap to clinical applications in therapy and diagnostics.
Export Options
About this article
Cite this article as:
Efferth Thomas, The Human ATP-Binding Cassette Transporter Genes From the Bench to the Bedside, Current Molecular Medicine 2001; 1 (1) . https://dx.doi.org/10.2174/1566524013364194
DOI https://dx.doi.org/10.2174/1566524013364194 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
InhaledInsulin: A Novel and Non-Invasive Way for Insulin Administration?
Current Drug Safety Recent Advances in the Allosteric Inhibition of Glycogen Phosphorylase
Mini-Reviews in Medicinal Chemistry Perspectives on Medicinal Properties of Benzoquinone Compounds
Mini-Reviews in Medicinal Chemistry Bacterial Protein Toxins: Current and Potential Clinical Use
Current Medicinal Chemistry Novel Approaches to the Treatment of Obesity and Type 2 Diabetes Mellitus: Bioactive Leptin-Related Synthetic Peptide Analogs
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Current Update in the Management of Diabetic Nephropathy
Current Diabetes Reviews State of the Art in African Trypanosome Drug Discovery
Current Topics in Medicinal Chemistry Novel Oral Anticoagulants in Peripheral Arterial and Coronary Artery Disease
Cardiovascular & Hematological Agents in Medicinal Chemistry Mitochondrial Dysfunction, Oxidative Stress and Diabetic Cardiovascular Disorders
Cardiovascular & Hematological Disorders-Drug Targets Type 1 Diabetes and Physical Exercise: Moving (forward) as an Adjuvant Therapy
Current Pharmaceutical Design Editorial [Hot Topic:Stabilizing the Vulnerable Plaque: The Search for the Magic Bullet (Executive Editors: G. Pasterkamp and M. Daemen)]
Current Pharmaceutical Design Impact of Microsomal Triglyceride Transfer Protein (MTP) in Preventing Hepatic Apoptosis
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Neuroimagenomics for the Study of Human Obesity
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) <i>In Vitro</i> Estimation of Photo-Protective Potential of Pomegranate Seed Oil and Development of a Nanoformulation
Current Nutrition & Food Science Modulation of Cardiac Metabolism During Myocardial Ischemia
Current Pharmaceutical Design CD40L - A Multipotent Molecule for Tumor Therapy
Endocrine, Metabolic & Immune Disorders - Drug Targets Neuroprotective Effects of Lithium - Pointing out Protein Phosphatases as Drug Targets?
Current Medicinal Chemistry - Central Nervous System Agents Vascular Risk Factors, Vascular Diseases, and Imaging Findings in a Hospital-based Cohort of Mild Cognitive Impairment Types
Current Alzheimer Research Cancer-Specific Ligands Identified from Screening of Peptide-Display Libraries
Current Pharmaceutical Design Alzheimer's Disease and NQO1: Is there a Link?
Current Alzheimer Research